Discovery of Jaspamycin from marine-derived natural product based on MTA3 to inhibit hepatocellular carcinoma progression
Abstract Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-024-75205-7. Article type: Research Article Keywords: MTA3, Pan-cancer, Hepatocellular carcinoma, Marine-derived anticancer agent, Jaspamycin, Cancer, Computational biology and bioinformatics, Drug discovery, Biomarkers, Gastroenterology, Oncology Authors: Yihan Liu, Tong Lu, Runze Li, Rui Xu, Denis Baranenko, Lida Yang, Dan Xiao Affiliations: https://ror.org/05x1ptx12grid.412068.90000 0004 1759 8782Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150001 China; https://ror.org/01kzgyz42grid.412613.30000 0004 1808 3289Medical Technology Department, Qiqihar Medical University, Qiqihar, Heilongjiang, 161006 China; https://ror.org/01yqg2h08grid.19373.3f0000 0001
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
